Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 528 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes

NCT02281084

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +12 more
Locations
  • Local Institution - 113 New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 89 locations
View Trial Details
Completed

A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies

NCT01943851

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +19 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 15 locations
View Trial Details
Completed

Ravulizumab Subcutaneous (SC) Versus Ravulizumab Intravenous (IV) in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

NCT03748823

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Liverpool, Australia
  • Research Site Parkville, Australia
  • Research Site Vienna, Austria
View all 51 locations
View Trial Details
Completed

IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT

NCT04522895

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations
  • University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology Düsseldorf, North Rhine-Westphalia, Germany
  • Uniklinik RWTH Aachen Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation (Med. Klinik IV) Aachen, Germany
  • Universitätsklinikum Köln Klinik I für Innere Medizin Cologne, Germany
  • Universitätsklinikum Carl Gustav Carus Medizinische Klinik und Poliklinik I Dresden, Germany
View Trial Details
Completed

The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV

NCT03003325

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • U.O. Ematologia, Ospedale Casa Sollievo della Sofferenza Istituto di Ricovero e Cura a Carattere Scientifico San Giovanni Rotondo, (FG) Puglia, Italy
  • U.O. Ematologia con Trapianto, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari Bari, Apulia, Italy
  • Azienda Ospedaliera Universitaria Federico II di Napoli Naples, Campania, Italy
  • Divisione Ematologia Policlinico S. Orsola - Malpighi Bologna, Emilia-Romagna, Italy
View all 23 locations
View Trial Details
Completed

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

NCT03814005

Conditions
Bone Marrow Diseases, Chronic Disease, Digestive System Diseases, +22 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • ICO lHospitalet Hospital Duran i Reynals LHospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Vall d'Hebron - PPDS Barcelona, Spain
View Trial Details
Completed

Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

NCT02907359

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Cancer Specialists of North Florida Fleming Island, Florida, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
View all 112 locations
View Trial Details
Completed

Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS)

NCT02103478

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Horizon Oncology Lafayette, Indiana, United States
View all 17 locations
View Trial Details

Related conditions